Improved diagnostics and prognostics of lung cancer and metastases to the lungs
61 – 70 of 87
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Protein-altering germline mutations implicate novel genes related to lung cancer development
- Contribution to journal › Article
-
Mark
Radiologisk och histologisk bild för en ökad förståelse vid covid-19
- Contribution to journal › Debate/Note/Editorial
-
Mark
Diagnostic value of insulinoma-associated protein 1 (INSM1) and comparison with established neuroendocrine markers in pulmonary cancers
- Contribution to journal › Article
- 2019
-
Mark
Shared heritability and functional enrichment across six solid cancers
- Contribution to journal › Article
-
Mark
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11
- Contribution to journal › Article
-
Mark
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer
- Contribution to journal › Article
-
Mark
Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC
- Contribution to journal › Article
-
Mark
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases
- Contribution to journal › Article
-
Mark
Circulating high sensitivity C reactive protein concentrations and risk of lung cancer : Nested case-control study within Lung Cancer Cohort Consortium
- Contribution to journal › Article
-
Mark
Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
- Contribution to journal › Article
